Epidermal growth factor (EGF) transfection of human bone marrow stromal cells in bone tissue engineering

Journal of Cellular and Molecular Medicine

Volumn 13, Issue 8 B, 2009, Pages 2593-2601

  Wallmichrath, J ^a,b   Stark, G B ^b   Kneser, U ^b,c   Andree, C ^b,d   Voigt, M ^b,e   Horch, R E ^b,c   Schaefer, D J ^b,f  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^d SANA KLINIKUM OFFENBACH   (Germany)

^e Plastic Aesthetic Surgery Freiburg   (Germany)

^f UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

BMSC; Bone marrow stromal cells; Bone tissue engineering; EGF; Epidermal growth factor; Gene therapy; Lipofection; Lipotransfection; Non viral gene transfer; Proliferation

Indexed keywords

EPIDERMAL GROWTH FACTOR; RECOMBINANT PROTEIN;

ARTICLE; BONE MARROW CELL; CULTURE MEDIUM; CYTOLOGY; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETIC TRANSFECTION; HUMAN; STROMA CELL; TISSUE ENGINEERING;

BONE MARROW CELLS; CULTURE MEDIA; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPIDERMAL GROWTH FACTOR; HUMANS; RECOMBINANT PROTEINS; STROMAL CELLS; TISSUE ENGINEERING; TRANSFECTION;

BOVINAE;

EID: 72949094901     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2008.00600.x     Document Type: Article

References (39)

1. Hutmacher DW, Cool S. Concepts of scaffold -based tissue engineering - the rationale to use solid free-form fabrication techniques. J Cell Mol Med. 2007 11 : 654 669.
2. Langer R, Vacanti JP. Tissue Engineering. Science. 1993 260 : 920 926. (Pubitemid 23209960)
3. Haynesworth SE, Baber MA, Caplan AI. Cell surface antigens on human marrow-derived mesenchymal cells are detected by monoclonal antibodies. Bone. 1992 13 : 69 80.
4. Wakitani S, Goto T, Pineda SJ, et al. Mesenchymal cell-based repair of large, full-thickness defects of articular cartilage. J Bone Joint Surg Am. 1994 76 : 579 592.
5. Pittenger MF, Mackay AM, Meck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999 284 : 143 147.
6. Caplan AI. Mesenchymal stem cells. J Orthop Res. 1991 9 : 641 650.
7. Fan VH, Au A, Tamama K, et al. Tethered epidermal growth factor provides a survival advantage to mesenchymal stem cells. Stem Cells. 2007 25 : 1241 1251.
8. Andree C, Swain WF, Page CP, et al. In vivo transfer and expression of a human epidermal growth factor gene accelerates wound repair. Proc Natl Acad Sci. 1994 91 : 12188 12192.
9. Cassiede P, Dennis JE, Ma F, et al. Osteochondrogenic potential of marrow mesenchymal progenitor cells exposed to TGF-beta1 or PDGF-BB as assayed in vivo and in vitro. J Bone Miner Res. 1996 11 : 1264 1273.
10. Kneser U, Schaefer DJ, Polykandriotis E, et al. Tissue engineering of bone: the reconstructive surgeon's point of view. J Cell Mol Med. 2006 10 : 7 19.
11. Bruder SC, Fink DJ, Caplan AI. Mesenchymal stem cells in bone development, bone repair, and skeletal regeneration therapy. J Cell Biochem. 1994 56 : 283 294.
12. Logeart-Avramoglou D, Anagnostou F, Bizios R, et al. Engineering bone: challenges and obstacles. J Cell Mol Med. 2005 9 : 72 84.
13. Sato H, Kuwashima N, Sakaida T, et al. Epidermal growth factor receptor-transfected bone marrow stromal cells exhibit enhanced migratory response and therapeutic potential against murine brain tumors. Cancer Gene Ther. 2005 12 : 757 768.
14. Ball SA, Shuttleworth A, Kielty CM. Mesenchymal stem cells and neovascularization: role of platelet-derived growth factor receptors. J Cell Mol Med. 2007 11 : 1012 1030.
15. Allay JA, Dennis JE, Haynesworth SE, et al. LacZ and Interleukin-3 expression in vivo after retroviral transduction of marrow-derived human osteogenic mesenchymal progenitors. Hum Gene Ther. 1997 8 : 1417 1427.
16. Radice M, Brun P, Cortivo R, et al. Hyaluronan-based biopolymers as delivery vehicles for bone-marrow-derived mesenchymal progenitors. J Biomed Mater Res. 2000 50 : 101 109.
17. Kim S, Honmou O, Kato K, et al. Neural differentiation potential of peripheral blood- and bone-marrow-derived precursor cells. Brain Res. 2006 1123 : 27 33.
18. Thomson JA, Itskovitz-Eldor J, Shapiro SS, et al. Embryonic stem cell lines derived from human blastocysts. Science. 1998 282 : 1145 1147.
19. Lasic DD. Liposomes in gene delivery. CRC Press, Boca Raton, New York 1997.
20. Baksh D, Song I, Tuan RS. Adult mesenchymal stem cells: characterization, differentiation, and application in cell and gene therapy. J Cell Mol Med. 2004 8 : 301 316.
21. Ozaki Y, Nishimura M, Sekiya K, et al. Comprehensive analysis of chemotactic factors for bone marrow mesenchymal stem cells. Stem Cells Dev. 2007 16 : 119 129.
22. Tamama K, Fan VH, Griffith LG, et al. Epidermal growth factor as a candidate for ex vivo expansion of bone marrow-derived mesenchymal stem cells. Stem Cells. 2006 24 : 686 695.
23. Grasser WA, Orlic I, Borovecki F, et al. BMP-6 exerts its osteoinductive effect through activation of IGF-I and EGF pathways. Int Orthop. 2007 31 : 759 765.
24. Schlessinger J. Ligand-induced, receptor-mediated dimerization and activation of EGF receptor. Cell. 2002 110 : 669 672.
25. Sibilia M, Kroismayr R, Lichtenberger BM, et al. The epidermal growth factor receptor: from development to tumorigenesis. Differentiation. 2007 75 : 770 787.
26. Nakahara H, Takaoka K, Koezuka M, et al. Periostal bone formation elicited by partially purified bone morphogenetic protein. Clin Orthop Relat Res. 1989 239 : 299 305.
27. Cho M-I, Garant PR. Expression and role of epidermal growth factor receptors during differentiation of cementoblasts, osteoblasts, and periodontal ligament fibroblasts in the rat. Anat Rec. 1996 245 : 342 360.
28. Schreiber AB, Winkler ME, Derynck R. Transforming growth factor-alpha: A more potent angiogenic mediator than epidermal growth factor. Science. 1986 4755 : 1250 1253.
29. Ng KW, Partridge NC, Niall M, et al. Epidermal growth factor receptors in clonal lines of rat osteogenic sarcoma and in osteoblast-rich rat bone cells. Calcif Tissue Int. 1983 35 : 298 303.
30. Paunescu V, Deak E, Herman D, et al. In vitro differentiation of human mesenchymal stem cells to epithelial lineage. J Cell Mol Med. 2007 11 : 502 508.
31. Bleiziffer O, Eriksson E, Yao F, et al. Gene transfer strategies in tissue engineering. J Cell Mol Med. 2007 11 : 206 223.
32. Partridge KA, Oreffo ROC. Gene delivery in bone tissue engineering: Progress and prospects using viral and nonviral strategies. Tissue Eng. 2004 10 : 295 307.
33. Jain VK. Vectors with bidirectional reporter genes for studying divergent promoters. Methods Enzymol. 1996 273 : 319 331.
34. Li S, Ma Z. Nonviral gene therapy. Curr Gene Ther. 2001 1 : 201 226.
35. Aluigi M, Fogli M, Curti A, et al. Nucleofection is an efficient non-viral transfection technique for human bone marrow-derived mesenchymal stem cells. Stem Cells. 2007 24 : 454 461.
36. Bebok Z, Abai AM, Dong JY, et al. Efficiency of plasmid delivery and expression after lipid-mediated gene transfer to human cells in vitro. J Pharmacol Exp Ther. 1996 279 : 1462 1469.
37. Franceschi R, Wang D, Krebsbach PH, et al. Gene therapy for bone formation: in vitro and in vivo osteogenic activity of an adenovirus expressing BMP7. J Cell Biochem. 2000 78 : 476 486.
38. Turgemann G, Pittmann DD, Muller R, et al. Engineered human mesenchymal stem cells: A novel platform for skeletal cell mediated gene therapy. J Gene Med. 2001 3 : 240 251.
39. Ripamonti U. Soluble, insoluble and geometric signals sculpt the architecture of mineralized tissues. J Cell Mol Med. 2004 8 : 169 180.